Personalized Cardiovascular Medicine
This course will review arterial inflammation, oxidative stress and vascular immune function, that lead to endothelial dysfunction, vascular functional and structural disease, CHD and CHF. Course faculty will highlight advanced CV testing.
Mark Houston, MD, MS, MSc
AIHM 2019 Annual Conference
Time to Complete
What you will learn
Infinite insults to the CV system result in three (3) finite responses to the artery: inflammation, oxidative stress and vascular immune function, that lead to endothelial dysfunction, vascular functional and structural disease, CHD and CHF. Endothelial dysfunction is the earliest marker and predictor of future CHD. The cardiovascular system is an innocent bystander to the correct defensive response to these infinite insults that become chronically dysregulated. CV medicine is a process as are other “diseases” and all are interrelated within a metabolic systems biology approach. Start early detection with evaluation of biomarkers, expanded advanced CHD risk factor analysis, micronutrient testing, risk scoring systems, CV genetics, gene expression testing and non invasive and invasive cardiovascular testing. There is a continuum of risk with all CHD risk factors. Begin aggressive scientifically proven nutrition, nutraceutical supplements and medications for prevention and treatment of CHD and CHF.By the end of this course, learners will be able to:
- Develop a logical approach to personalized and precision cardiovascular medicine.
- Apply cardiovascular genomics, nutrigenomics and gene expression testing.
- Explain non-invasive vascular testing such as EndoPAT, CAPWA (computerized arterial pulse wave analysis) and CAC ( coronary artery calcium score), carotid duplex, autonomic function testing, ECHO and stress ECHO, CPET, MCG, retinal scans, watchPat.
- Apply cardiovascular risk scoring systems.
- Apply advanced cardiovascular lab testing for CV risk.
Certificate of Completion
Included in this course
Mark Houston, MD, MS, MSc
AIHM Faculty, Fellowship
Faculty Disclosures: This speaker has no relevant relationships with commercial interests to disclose.
Dr. Mark Houston is Associate Clinical Professor of Medicine at Vanderbilt University School of Medicine, Clinical Instructor in the Department of Physical Therapy and Health Care Sciences at George Washington University (GWU), Adjunct Professor in Metabolic Medicine at the University of South Florida Medical School, Director of the Hypertension Institute and Vascular Biology and Medical Director of the Division of Human Nutrition at Saint Thomas Hospital in Nashville, TN. He is on the faculty and Director of the Advanced Cardiovascular Modules 16 for MMI/A4M in the US and Director of the Cardiovascular Module 2 for MMI.
Physicians earn a maximum of 1.00 AMA PRA Category 1 Credit(s)™. The subscription period for this CME-eligible course is until June 24, 2022.
All other healthcare professionals completing this activity will be issued a certificate of participation. Physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must review the content and complete the activity evaluation, followed by the post-test online during the subscription period. After the subscription period, you will continue to have access to your purchased content, however you will no longer be able to claim CME credits for your participation in the course.
This course is self-paced with no set beginning or end date. You may complete this course on your own schedule and pace. Enrolling in and purchasing this course grants you access to its contents in perpetuity.